Indole-based carbohydrazides as potent anti-proliferative leads and tubulin polymerization inhibitors: design, synthesis, cytotoxic evaluation, in silico ADMET and docking studies
- 25 June 2026
- journal article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 18 (15) , 1-15
Abstract
A novel series of indolecarbohydrazide derivatives (3a-r) was designed and synthesized to evaluate their potential as tubulin polymerization inhibitors and selective anticancer agents. The cytotoxic potential of compounds 3a-r was assessed against six human cancer cell lines and nonmalignant RPE-1 cells. Mechanistic studies included tubulin polymerization assays, cell cycle analysis, and apoptosis induction. Pharmacokinetic profiles were predicted using SwissADME, while molecular docking (MOE-Dock v2024.0601) explored binding affinities at the colchicine site. Compounds 3b, 3d, 3i, and 3p showed significant potency against MCF-7 cells, with 3i being the most active (IC50 = 1.0 ± 0.05 mM), outperforming doxorubicin. Derivatives 3d and 3i effectively inhibited tubulin polymerization (IC50 = 3.96 and 6.28 μM, respectively), comparable to combretastatin A4. Compound 3d induced G2/M phase arrest and apoptosis, consistent with microtubule disruption. In silico analysis predicted favorable drug-like properties, and docking scores (-9.28 to -10.92 kcal/mol) confirmed high affinity for the colchicine binding site. These findings identify the indolecarbohydrazide scaffold as a potent anti-proliferative lead that successfully disrupts tubulin dynamics, offering a promising foundation for further development of colchicine-site microtubule-targeting agents.Keywords
Funding Information
- Princess Nourah Bint Abdulrahman University (PNURSP2026R116)
This publication has 48 references indexed in Scilit:
- New alkanesulfonate-based quinazolinone-acetohydrazide scaffolds: Rational design, synthesis, molecular docking, anticancer properties and potential EGFR and its T790M/L858R mutants inhibitorsBioorganic Chemistry, 2025
- Design, synthesis, anti-inflammatory evaluation and molecular docking of novel thiophen-2-ylmethylene-based derivatives as potential TNF-α production inhibitorsBioorganic Chemistry, 2022
- Indole derivatives as tubulin polymerization inhibitors for the development of promising anticancer agentsBioorganic & Medicinal Chemistry, 2022
- Design, synthesis and biological evaluation of novel 2-phenyl-4,5,6,7-tetrahydro-1H-indole derivatives as potential anticancer agents and tubulin polymerization inhibitorsArabian Journal of Chemistry, 2022
- Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure–activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic studyBioorganic Chemistry, 2021
- Synthesis of nitrogen, phosphorus, selenium and sulfur-containing heterocyclic compounds – Determination of their carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibition propertiesBioorganic Chemistry, 2020
- Tetrahydroindoles as Multipurpose Screening Compounds and Novel Sirtuin InhibitorsChemMedChem, 2019
- An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding SitePharmaceutical Research, 2012
- Indole, a core nucleus for potent inhibitors of tubulin polymerizationMedicinal Research Reviews, 2006
- The hypothalamic somatostatinergic pathways mediate feeding behavior in the ratCellular and Molecular Life Sciences, 1989